BioSpace News Archive

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that the Company has received its first delivery of manufacturing equipment at its Cobourg plant from Canntab Therapeutics Limited (CSE:PILL) (“Canntab”), a leader in the rapidly growing cannabis pill market

Gluten-Free New England, LLC is delighted to present the region’s premier resource for healthy gluten-free living. Their just-launched website offers a dining directory, events calendar, reviews, recipes, and articles contributed by local writers and experts. They also organize large-scale expos, festivals, and farm dinners, and provide outreach for teens and young families.

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced results from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial, demonstrating that ALUNBRIG reduced the risk of disease progression or death, known as progression-free survival (PFS)

Andrew J. Garnett, SNG founder, president & CEO of Special Needs Group® / Special Needs at Sea® (SNG) www.specialneedsgroup.com, is pleased to announce that the company recently won two awards in the 2018 Travel Weekly Magellan Awards (gold in the Hospitality ? Overall, Special Needs Category, and silver in the Cruise - Overall, Special Needs Category).

Veratad Technologies, LLC (veratad.com), an innovative and industry leading provider of global online identity verification, age verification, and fraud prevention solutions, announced today they have joined NJ Tech Council (njtc.org), an organization for technology companies and organizations as well as tech related professional providers/advisors.

omprehend Systems, the leader in Clinical Intelligence software, announced today a new offering for mid-sized CROs to standardize on a risk platform to address their sponsor needs. CROs are operating in a highly competitive and complex business environment.

CipherHealth is pleased to announce it has named Jake Pyles as its new Chief Financial Officer (CFO).

Neogen Corporation (Nasdaq: NEOG) announced today that net income for the first quarter of its 2019 fiscal year, which ended Aug. 31, increased 28% to $15,237,000, from the previous year’s first quarter net income of $11,914,000

TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced the launch of its Clinical Trial Transparency Service (CTTS). This transparency and health literacy management solution enables clinical trial sponsors to engage with patients, healthcare professionals, researchers and the public via a dedicated clinical trial informational website.

LifeWalletsm has joined Premier’s Healthcare Innovators Collaborative.